Skip to main content
Caplight Logo









Vitall

Vitall

Private
BasildonHealthcare & Life Scienceshttps://vitall.co.uk/

Last Round

Grant

Apr 1, 2022

Total Funding Raised

$4.78M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Vitall operates in Healthcare & Life Sciences and is based in Basildon. Its latest recorded funding round was a Grant round in April 2022.

Vitall is a digital health company that provides at-home health testing services and diagnostic insights for individuals and organizations.

Sector

Healthcare & Life Sciences

Verticals

Data Integration, EHR & EMR, API Management

Business Model

B2B

Customer Profile

Usage-Based SaaS, Data as a Service, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Vitall Comparables

Compare Vitall with similar companies based on industry and business-model similarity.

Vitall comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Datavant
77%
Graphnet Health
76%
Particle Health
73%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Vitall Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 1, 2022
SeedJan 19, 2022
AcceleratorSep 12, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Vitall Investors

Notable investors and investment history

Vitall investors
InvestorRounds
SBRI HealthcareGrant
DigitalHealth.LondonGrant, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 62% MoM.

  • Jan 25, 2026

    Monthly visitors increased 51% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Vitall Filings

Explore SEC and related filing metadata, where available.

Vitall filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Vitall's valuation, stock price, and market status.

Is Vitall a public or private company?

Vitall is a private company.

What is the current stock price of Vitall?

Vitall is a private company, so its shares have no public market price. Caplight tracks Vitall's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Vitall worth (valuation)?

Valuation information for Vitall is not publicly available.

Can I buy Vitall stock?

Vitall shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Vitall's last funding round?

Vitall's most recent funding round was Grant on April 1, 2022.

Who are the main investors in Vitall?

Key investors in Vitall include SBRI Healthcare, DigitalHealth.London.

Will Vitall IPO soon?

No public IPO plans have been announced for Vitall.

How can I track Vitall secondary market activity?

Caplight tracks bids, offers, and trades in Vitall's shares on secondary markets.

Firmographic Details

HeadquartersBasildon
Employee Range2
Year Founded2018
Last FundingApr 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?